KELLY DART: Open Payments
NPI 1639670656 · LAKEWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,120 in 36 payments from 11 companies in 2025. Trend: 2023 $138 · 2024 $780 · 2025 $1,120
Food & beverage: $925Education: $195
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $291 |
| AstraZeneca Pharmaceuticals LP | 5 | $241 |
| SANOFI-AVENTIS U.S. LLC | 2 | $195 |
| GENZYME CORPORATION | 12 | $171 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
| Amgen Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $23 |
| Organon LLC | 2 | $20 |
| ALK-Abello, Inc | 1 | $19 |
Products named: DUPIXENT, AIRSUPRA, Rhapsido, NUCALA, TEZSPIRE, FASENRA, TALTZ, Ragwitek.
Industry payments across WA — which companies pay providers there.
